Reliefband Technologies LLC (Philadelphia), a private company, reported it has raised $5 million in venture capital funding since it was established in July. The company will use the funding to fuel the consumer market introduction of Reliefband, an FDA-cleared wearable device that uses neuromodulation for the treatment of nausea.